Your browser doesn't support javascript.
loading
The case of the neonate vs. LMIC medical academia-a jury-style systematic review of 32 years of literature without significant mortality reduction.
Amadi, Hippolite O; Abioye, Ifeoluwa O; Ugbolue, Ukadike C; Ekpenyong, Rhoda-Dara; Ekwem, Nnamdi F; Nwaneri, Ogechi J; Dike, Chidiebere.
Afiliación
  • Amadi HO; Department of Bioengineering, Imperial College London, London, United Kingdom.
  • Abioye IO; Division of Precision Health, Quality and Safety Leadership, University of Calgary, Alberta, AB, Canada.
  • Ugbolue UC; Biomechanics Laboratory, Division of Sports and Exercise, University of the West of Scotland, Glasgow, United Kingdom.
  • Ekpenyong RD; Department of Paediatrics, University of Calabar, Calabar, Nigeria.
  • Ekwem NF; Corporate & Commercial Law, Frederick & Co., Barristers and Associates, Abuja, Nigeria.
  • Nwaneri OJ; Division of Nursing Education, School of Nursing & Midwifery, Mount Royal University, Alberta, AB, Canada.
  • Dike C; Health and Education Department, Manchester Metropolitan University, Manchester, United Kingdom.
Front Pediatr ; 12: 1413113, 2024.
Article en En | MEDLINE | ID: mdl-39105159
ABSTRACT

Introduction:

The high neonatal mortality rate in low- and middle-income countries (LMICs) such as Nigeria has lasted for more than 30 years to date with associated nursing fatigue. Despite prominent hard work, technological improvements, and many publications released from the country since 1990, the problem has persisted, perhaps due to a lack of intervention scale-up. Could there be neglected discoveries unwittingly abandoned by Nigerian policymakers over the years, perhaps locked up in previous publications? A careful review may reveal these insights to alert policymakers, inspire researchers, and refocus in-country research efforts towards impactful directions for improving neonatal survival rates. The focus was to determine the prevailed effectiveness of LMIC medical academia in creating solutions to end the high neonatal mortality rate.

Methods:

An unconventional systematic review protocol structure following the PRISMA 2020 checklist was designed and registered at INPLASY (registration number INPLASY202380096, doi 10.37766/inplasy2023.8.0096). A jury of paediatricians was assembled and observed by a team of legal professionals. The jury searched the literature from 1990 to the end of 2022, extracted newborn-related articles about Nigeria, and assessed and debated them against expected criteria for solution creation, translation, scale-up, sustainability, and national coverage. Each juror used preset criteria to produce a verdict on the possibility of a published novel idea being a potential game-changer for improving the survival rate of Nigerian neonates.

Results:

A summation of the results showed that 19 out of 4,286 publications were assessed to possess potential strategies or interventions to reduce neonatal mortality. Fourteen were fully developed but not appropriately scaled up across the country, hence denying neonates proper access to these interventions.

Conclusion:

Nigeria may already have the required game-changing ideas to strategically scale up across the nation to accelerate neonatal survival. Therefore, LMIC healthcare systems may have to look inward to strengthen what they already possess. Systematic Review Registration https//inplasy.com/, identifier (INPLASY202380096).
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pediatr Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pediatr Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza